Arkolith/Insider Trading/ALDX/Form 4

Walker Neal

DirectorAldeyra Therapeutics, Inc. (ALDX) · full profile →Form 4 · filed Jul 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2023Grant(A)21K—$021K
Jun 30, 2023Grant(A)915—$0915

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-031775) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML